Episode Details

Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls up Ernesto Londoño, reporter at the New York Times and author of the new book, “Trippy: The Peril and Promise of Medicinal Psychedelics.” They discuss his own mental health and psychedelic journeys and why he thinks there’s good reason for both hope and skepticism. 

Learn more about your ad choices. Visit podcastchoices.com/adchoices